相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Imaging characteristics of adult H3 K27M-mutant gliomas
Tianming Qiu et al.
JOURNAL OF NEUROSURGERY (2020)
H3F3A mutant allele specific imbalance in an aggressive subtype of diffuse midline glioma, H3 K27M-mutant
Sachi Maeda et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2020)
Targeting and Therapeutic Monitoring of H3K27M-Mutant Glioma (vol 22, 19, 2020)
Kyle Wierzbicki et al.
CURRENT ONCOLOGY REPORTS (2020)
Clinical and Molecular Characteristics of Thalamic Gliomas: Retrospective Report of 26 Cases
Yikui Liu et al.
WORLD NEUROSURGERY (2019)
H3K27M, IDH1, and ATRX expression in pediatric GBM and their clinical and prognostic significance
Alok Mohan Uppar et al.
CHILDS NERVOUS SYSTEM (2019)
Preclinical therapeutic targets in diffuse midline glioma
Michael Hananja Meel et al.
DRUG RESISTANCE UPDATES (2019)
Histone H3.3 K27M Accelerates Spontaneous Brainstem Glioma and Drives Restricted Changes in Bivalent Gene Expression
Jon D. Larson et al.
CANCER CELL (2019)
Diffuse high-grade gliomas with H3 K27M mutations carry a dismal prognosis independent of tumor location
Michael Karremann et al.
NEURO-ONCOLOGY (2018)
Circumscribed/non-diffuse histology confers a better prognosis in H3K27M-mutant gliomas
Drew Pratt et al.
ACTA NEUROPATHOLOGICA (2018)
cIMPACT-NOW update 2: diagnostic clarifications for diffuse midline glioma, H3 K27M-mutant and diffuse astrocytoma/anaplastic astrocytoma, IDH-mutant
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2018)
H3 K27M-mutant gliomas in adults vs. children share similar histological features and adverse prognosis
Bette K. Kleinschmidt-DeMasters et al.
CLINICAL NEUROPATHOLOGY (2018)
Clinically Relevant and Minimally Invasive Tumor Surveillance of Pediatric Diffuse Midline Gliomas Using Patient-Derived Liquid Biopsy
Eshini Panditharatna et al.
CLINICAL CANCER RESEARCH (2018)
Characteristics of H3 K27M-mutant gliomas in adults
David Meyronet et al.
NEURO-ONCOLOGY (2017)
Comparative Assessment of 4 Methods to Analyze MGMT Status in a Series of 121 Glioblastoma Patients
Chih-Yi Hsu et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2017)
Absence of MGMT promoter methylation in diffuse midline glioma, H3 K27M-mutant
Rouzbeh Banan et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2017)
Diffuse Midline Gliomas with Histone H3-K27M Mutation: A Series of 47 Cases Assessing the Spectrum of Morphologic Variation and Associated Genetic Alterations
David A. Solomon et al.
BRAIN PATHOLOGY (2016)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
Maximizing safe resection of low- and high-grade glioma
Shawn L. Hervey-Jumper et al.
JOURNAL OF NEURO-ONCOLOGY (2016)
Pilocytic astrocytoma and glioneuronal tumor with histone H3 K27M mutation
Cordelia Orillac et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2016)
Use of human embryonic stem cells to model pediatric gliomas with H3.3K27M histone mutation
Kosuke Funato et al.
SCIENCE (2014)
Reduced H3K27me3 and DNA Hypomethylation Are Major Drivers of Gene Expression in K27M Mutant Pediatric High-Grade Gliomas
Sebastian Bender et al.
CANCER CELL (2013)
Histone methylation: a dynamic mark in health, disease and inheritance
Eric L. Greer et al.
NATURE REVIEWS GENETICS (2012)
分享论文
